Full-Time

Senior Principal Program Manager

Manufacturing Solutions

Posted on 10/30/2025

Deadline 10/7/26
Waters Corporation

Waters Corporation

10,001+ employees

Analytical instruments, software, and services provider

No salary listed

Franklin, MA, USA

In Person

Category
Business & Strategy (1)
Required Skills
SAP Products
Requirements
  • Bachelor of Science in Mechanical, Electrical, Industrial or Manufacturing Engineering; Advanced degree preferred
  • 12+ years of dynamic experience in program and project management with a consistent record of successfully completing large-scale programs delivering technological introduction and/or manufacturing evolution changes producing expected results
  • Project Management experience; PMP certification preferred; Scrum Master certifications a plus
  • Experience with estimating costs for capital equipment (materials, labor, and engineering) for processing automation
  • Experience with SAP and Microsoft applications
  • Comprehensive Knowledge of process automation and control components, motion and logic controls and equipment design
  • Machine safety implementation across semi, fully automated equipment
  • Experience with Allen-Bradley (Control Logix, Compact Logix, PanelView), Siemens products and industrial networks, Vision systems, steppers, servo, robotics, pneumatics, and electronics
  • Change management experience
  • Strong leadership, self-directed, independent decision-making, influence change
  • Excellent organizational, interpersonal, verbal, written and presentation skills
  • Familiarity with cGMP, ISO 9001:2015 and ISO 13485:2016 highly desired
  • Budget management experience
  • Ability to develop business cases and defend capital investments
  • Lean Operating System deployment experience
  • Experience leading cross-functional teams and managing multiple concurrent projects
  • Ability to define problems, collect data, establish facts and drive corrective actions
  • Ability to work with IT, R&D, Global Operations to deploy digital solutions
  • Knowledge of digitalization / automation roadmaps and capital requirements for projects
Responsibilities
  • Ensure all initiatives carried out with Zero injury, through effective risk assessment, management of change and risk mitigation
  • Establish and maintain project management standards, tools, and best practices in Milford, while creating project culture and mindset across the functions and project owners
  • Works directly with all project business sponsors to articulate expected outcome, establishing metrics for measuring success ensuring that projects deliver value
  • Define digitalization / automation 3-5 years roadmap aimed to improve safety, quality and/or productivity; define capital requirements, gain approvals based on robust business cases and execute initiatives to achieve project success criteria
  • Work with IT, Business Partners, R&D, and Global Operations functions to develop and deploy technological advancements and digital solutions to drive efficient use of resources
  • Own capital investment cadence and ensuring cash flow is in consistency with project execution
  • Provide cadence and control of Milford Operations’ Capital Expenditure, ensuring discipline around appropriation and spending
  • Establish long-range capacity planning / modeling for Milford Operations
  • Lead cross-functional teams and generate project plans to ensure activities and deliverables are executed in a timely manner and to budget
  • Prioritize needs and effectively schedule projects and resources to support multiple projects in parallel
  • Report to Operations Management on a regular basis regarding program status, barriers, actions, and requests
  • Enable and accelerate deployment of Lean Operating System and support a continuous improvement mindset
  • Identify risks that could become a barrier and address those risk accordingly to make sure execution; mitigation plans around critical path; identify project interdependencies
  • Experience with estimating costs for capital equipment for processing automation
  • Identify opportunities for automation and scope out projects and develop comprehensive specifications to build custom automated machines and tools; manage projects from concept through completion
  • Perform research, review and develop manufacturing equipment and automation systems maximizing efficiencies, analyzing layout of equipment, workflow, assembly methods and work force utilization
  • Develop documentation related to automation and systems for standard operation, validation FAT, SAT, preventive maintenance, and troubleshooting
  • Ability to handle large scale automation projects for various departments, and comfortable managing multiple concurrent projects
Desired Qualifications
  • Scrum Master certifications
  • Advanced degree (preferred)
  • ISO 13485:2016 familiarity
  • cGMP familiarity
  • Experience with advanced manufacturing technologies and transformational programs beyond standard automation

Waters Corporation provides analytical system solutions, software, and services for scientists across biopharma, clinical research, forensics, life science research, food and beverage, and environmental sectors. Its products include high-performance analytical instruments like the BioAccord System, paired with software and ongoing support to enable precise, reproducible results. The company operates by selling instruments and software and offering maintenance and services to enhance user experience and reliability. Compared to competitors, Waters offers an integrated package of hardware, software, and service across multiple markets, focused on delivering accurate analyses and end-to-end workflow solutions rather than just standalone devices. Its goal is to unlock the potential of science by solving problems that affect human health and well-being.

Company Size

10,001+

Company Stage

IPO

Headquarters

Milford, Connecticut

Founded

1958

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 organic growth 11% constant currency; raised full-year guidance to 6.5-8%.
  • Acquired BD Biosciences unit exceeded revenue by $40M; targeting $55M cost synergies.
  • China pharmaceutical revenue grew 50%+ targeting biotech CDMOs and emerging domestic companies.

What critics are saying

  • Competitors release comparable MALS and blood culture systems within 12-18 months, eroding differentiation.
  • $3.5B debt at 4.3-5.2% creates refinancing cliff 2027-2036 if growth slows.
  • BD acquisition integration risks $55M synergy target; supply chain fragmentation could halve realized savings.

What makes Waters Corporation unique

  • BD BACTEC FXI detects bloodstream infections 3 hours faster with automated blood volume measurement.
  • omniDAWN MALS enables 4x faster large molecule analysis with 10x molar mass improvement.
  • ARES-G3 Rheometer reduces testing times 80% while capturing 25,000 data points per second.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

PR Newswire
Apr 14th, 2026
Waters launches omniDAWN MALS detector for UHPLC, enabling 4x faster analysis of large molecules

Waters Corporation has launched the omniDAWN Multi-Angle Light Scattering Photometer, the first extended-range MALS detector designed for ultra high performance liquid chromatography workflows. The device features 18 detection angles and delivers chromatographic run times up to four times faster than conventional methods. The photometer extends UPLC-compatible sizing tenfold, from approximately 50 to 500 nanometres in radius, enabling characterisation of complex molecules including protein aggregates, viral vectors and lipid nanoparticles. It achieves a 10-fold improvement in absolute molar mass measurements whilst reducing sample consumption by 30–50% and solvent use by roughly 40%. The device integrates with Waters UPLC systems and is powered by ASTRA software, supporting analysis across drug discovery, development and quality control. The omniDAWN photometer will be available globally in summer 2026.

PR Newswire
Apr 8th, 2026
Waters gains FDA clearance for at-home cervical cancer screening kit with HPV assay

Waters Corporation has received FDA clearance for the Onclarity HPV Self-Collection Kit and approval for the BD Onclarity HPV Assay with extended genotyping for at-home use. The kit enables cervical cancer screening from home, addressing barriers that prevent many individuals from routine testing. Approximately 60% of cervical cancer cases occur in unscreened or under-screened individuals. The BD Onclarity HPV Assay is the only FDA-approved test identifying six individual HPV genotypes and three pooled groups, making it the most comprehensive screening tool available in the US. The kit will be available by prescription in coming months and is covered by private insurance, Medicaid and Medicare. Waters is establishing partnerships for broader nationwide access, with patients able to collect samples at home and mail them to laboratories for processing.

Paul Hastings LLP
Mar 23rd, 2026
Waters Corporation subsidiary raises $3.5B through senior notes offering

Paul Hastings advised underwriters including Barclays Capital, Citigroup Global Markets and J.P. Morgan Securities in a $3.5 billion senior notes offering by Augusta SpinCo Corporation, a Waters Corporation subsidiary. The SEC-registered offering comprises five tranches of senior notes maturing between 2027 and 2036, with interest rates ranging from 4.321% to 5.245%. The notes are guaranteed by Waters and certain subsidiaries. Partner Jeff Ramsay led the Paul Hastings team, which included partners Morgan Bale, Ismael Duran and Daniel Nicholas, along with several associates.

Yahoo Finance
Mar 19th, 2026
Waters Corporation stock down 22.8% year-on-year, underperforming Dow's 11.2% rise

Waters Corporation (WAT), a leading scientific instruments manufacturer, is underperforming the Dow Jones Industrial Average significantly. The stock trades 28.8% below its 52-week high of $414.15 and has declined 22.3% year-to-date, compared to the Dow's 3.8% decline. The Milford, Massachusetts-based company, with a market cap of $28.9 billion, specialises in analytical technologies including liquid chromatography and mass spectrometry for pharmaceutical, life sciences and industrial applications. Despite reporting solid fourth-quarter results with revenue of $932 million, up 7% year-over-year, and adjusted earnings per share rising 10% to $4.53, investor sentiment has soured. Cautious first-quarter guidance and concerns over its acquisition of Becton Dickinson's biosciences unit, which is underperforming expectations, have weighed on the stock.

Yahoo Finance
Mar 17th, 2026
Waters Corporation Q4 results mixed as research tools sector faces 20.9% share price decline

Waters Corporation reported Q4 revenues of $932.4 million, down 45.4% year on year, meeting analysts' expectations. The analytical instruments manufacturer delivered mixed results, with next quarter's revenue guidance exceeding expectations but earnings per share guidance falling short. The research tools and consumables sector reported a satisfactory Q4 overall, with the 10 tracked stocks beating revenue consensus estimates by 1.2%. However, share prices have struggled, declining 20.9% on average since latest earnings results. Founded in 1958, Waters develops analytical instruments, software and consumables for liquid chromatography, mass spectrometry and thermal analysis. CEO Udit Batra highlighted the company achieved high single-digit revenue growth and double-digit adjusted EPS growth in 2025, with momentum expected to continue into 2026.

INACTIVE